Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.
National Centre of Disease Epidemiology, Prevention and Control, Ministry of Health, Peru.
Lancet Oncol. 2017 Oct;18(10):e573-e586. doi: 10.1016/S1470-2045(17)30377-7.
Peru, like several other South American countries, is experiencing remarkable population growth, ageing, and urbanisation, which has given rise to profound changes in its epidemiological profile. Prostate and breast cancer are the most frequent cancers in men and women, respectively, in Lima and Arequipa, the two areas with population-based cancer registries. However, infection-associated cancers (cervix and stomach) are also common, and rank highest in the national cancer mortality profile. Although a foundation of surveillance informs cancer-control initiatives in Peru, improvements in the vital statistics system, and the quality and use of incidence data for the planning and assessment of cancer prevention and control actions, are needed. Existing population-based cancer registries in Lima and Arequipa, and linkages to the established national mandatory cancer reporting system, are crucial for the collection of high-quality data on national cancer incidence. The delivery of effective cancer prevention and control measures requires sustained investment in the collection of high-quality data capable of informing policies and driving research programmes.
秘鲁与其他几个南美国家一样，正经历着显著的人口增长、老龄化和城市化，这导致其流行病学特征发生了深刻变化。在拥有基于人群的癌症登记处的利马和阿雷基帕这两个地区，前列腺癌和乳腺癌分别是男性和女性中最常见的癌症。然而，与感染相关的癌症（宫颈癌和胃癌）也很常见，在国家癌症死亡率中排名最高。尽管监测基础为秘鲁的癌症控制工作提供了信息，但仍需要改进生命统计系统，提高发病率数据的质量并加以利用，以规划和评估癌症的预防和控制措施。现有的利马和阿雷基帕基于人群的癌症登记处，以及与既定的国家强制性癌症报告制度的联系，对于收集高质量的全国癌症发病率数据至关重要。提供有效的癌症预防和控制措施需要持续投资于高质量数据的收集，以提供政策信息并推动研究计划。
